IBD - Latest News
Inspire Corporate Bond ETF (IBD), operates in Financial Services / Asset Management - Bonds, trades on AMEX.
Market capitalization stands near $463.4M, a proxy for assets under management on listed ETFs.
The article list below shows the most recent IBD headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent IBD Headlines
Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?
zacks.com - Oct 14, 2026
Launched on 07/10/2017, the Inspire Corporate Bond ETF (IBD) is a smart beta exchange traded fund offering broad exposure to the Investment Grade Corp
New SKYRIZI® (risankizumab-rzaa) and RINVOQ® (upadacitinib) Data Demonstrate Disease Control for Patients Living With Inflammatory Bowel Disease
gurufocus.com - Oct 11, 2026
New SKYRIZIÂ (risankizumab-rzaa) and RINVOQÂ (upadacitinib) Data Demonstrate Disease Control for Patients Living With Inflammatory Bowel DiseasePR New
Celltrion to Present New Analyses of ZYMFENTRA® (infliximab-dyyb) in Crohn's Disease and Ulcerative Colitis at ACG 2026
gurufocus.com - Oct 11, 2026
Celltrion to Present New Analyses of ZYMFENTRAÂ (infliximab-dyyb) in Crohn's Disease and Ulcerative Colitis at ACG 2026PR NewswireJERSEY CITY, N. J.
New Opportunities for Global Cooperation: Kexing Biopharm Shines at CPHI Milan 2026
gurufocus.com - Oct 10, 2026
New Opportunities for Global Cooperation: Kexing Biopharm Shines at CPHI Milan 2026PR NewswireMILAN, Oct. 10, 2026MILAN, Oct.
Spyre: Maintain 'Strong Buy' On Additional SPY072 Shots On Goal Q4 2026 And IBD Combination Potential
seekingalpha.com - Oct 7, 2026
Spyre Therapeutics maintains a 'Strong Buy' rating, driven by promising IBD pipeline progress and robust cash reserves. SYRE's three monotherapy cand
How News Affects IBD Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track IBD's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked IBD news questions
- What is the latest IBD news headline?
- The most recent IBD headline (Oct 14, 2026) is "Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the IBD news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What IBD news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual IBD options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.